Option chain shows key data for Urologix's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Urologix.

Urologix (OTC:ULGX) Stock, Option Chain

Urologix Inc is a United States-based company engaged in the development, manufacturing, and marketing of minimally invasive medical products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The firm markets the Cooled ThermoTherapy (CTC) product line and the Prostiva Radio Frequency (RF) Therapy System (Prostiva). The CTC produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. The Prostiva delivers radio frequency energy directly into the prostate destroying prostate tissue, reducing constriction of the urethra, and thereby relieving BPH voiding symptoms. The CTC product line includes the CoolWave and Targis Control Units and the CTC Advance catheter.

Urologix, Inc.

News

Intraday Update

Markets

Movers

Trading Ideas

AAVMY

ABCE

ACRX

ACSAY

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALOT

AMGDF

APLE

APRN

ASIX

ATRO

ATUSF

AYTU

BCDRF

BFCH

BICEY

BNPUF

BOIVF

BORR

CDEV

CDZI

CESTY

CHRW

CJPRY

CJREF

CLVLF

CNDT

COWI

CPMD

CRWG

CSOD

China Shenhua Energy Unsponsored representing A shares

CSUAY

CTHR

CULP

CUYTF

CWSFF

CWVWF

CXXIF

DGRLY

DIFTY

DIIBF

DLTH

DMRC

DNTUY

DSSI

DXBRF

EJPRY

EKTAF

EKTAY

AB Electrolux Class B American Depositary Receipts

ELUXY

ELVT

ENLC

EZPW

FANG

FARE

FLMN

FLOOF

FLWPF

GGTTF

GLYE

GOGL

GPDNF

Stocks That Hit 52-Week Lows On Tuesday

Movers & Shakers

General

ACNNF

AEMD

AESE

AGHI

AIRG

AKER

AMCX

AMRH

AMRK

ANDR

APAAF

ATADF

BNKPF

BOSC

BRGO

CADMF

CFWFF

CHKIF

CLXT

CNGGF

CPPMF

CPYT

DELRF

DIALF

DLPN

DLUEY

DTNOF

ECIFY

EGRAF

EVLO

FDMF

FITX

GARB

GDRZF

GLOP

GMHLF

GNAL

GOHE

GRSO

GTBP

HAON

HENC

HGHAF

HHPHF

HVBTF

IDXG

IMBBY

IMTV

INAP

INDXF

INND

INNMF

IPIX

JBFCF

JBFCY

JWCAF

KBSF

KWBT

LKCO

LTBR

LUCRF

GLOBALIVE TECH INC by Globalive Technology Inc.

LVVEF

MCEP

MDTR

MFST

MREO

MRIN

MTFB

NIMU

NOHO

NRGMF

NWCI

OCGN

PHVAF

PMGYF

PPCLY

PRGX

PRLE

PTNYF

PXPP

PZRXQ

RCKHF

RLBD

RMHB

RVSDF

SCNNF

SITO

SNDL

SNOA

SPLIF

SQNS

Long Ideas

Short Ideas

Management

Success Stories

ASUR

CJJD

COOL

NMAR

SABA

THQIQ

TSTC

ULGX

VECO

Can Companies Recover from a Nasdaq or NYSE Delisting?

Urologix Inc

BSTBF

DECXF

FRONTERA ENERGY CORP ORD by Frontera Energy Corp

FECCF

SIRZF

8-K from Urologix Shows CFO Brian Smrdel Resigned, Co. Has Named CEO Gregory Fluet as Interim CFO

Urologix, Inc. (NASDAQ: <a class="ticker" href="/stock/ulgx#NASDAQ">ULGX</a>) reports Q4 EPS of $(0.17) versus $(0.08) in the same quarter last year. Revenue came in at $3.30M versus $4.50M a year ago.

Earnings

Urologix, Inc. Reports Q4 EPS of $(0.17), Down 113% YOY; Revenue of $3.30M, Down 27% YOY

Urologix, Inc. (NASDAQ: <a class="ticker" href="/stock/ulgx#NASDAQ">ULGX</a>) reports Q3 EPS of $(0.08) versus $(0.08) in the same quarter last year. Revenue came in at $3.40M versus $4.50M a year ago.

Urologix, Inc. Reports Q3 EPS of $(0.08), Unchanged YOY; Revenue of $3.40M, Down 24% YOY

Urologix, Inc. (NASDAQ: <a class="ticker" href="/stock/ulgx#NASDAQ">ULGX</a>) sees Q3 sales of $3.40M.

Guidance

Urologix, Inc. Reports Prelim. Q3 Sales $3.40M

Urologix, Inc. (NASDAQ: <a class="ticker" href="/stock/ulgx#NASDAQ">ULGX</a>) reports Q2 EPS of $(0.05) versus $(0.08) in the same quarter last year. Revenue came in at $3.81M versus $4.50M a year ago.

Urologix, Inc. Reports Q2 EPS of $(0.05), Up 38% YOY; Revenue of $3.81M, Down 15% YOY

Urologix, Inc. (NASDAQ: <a class="ticker" href="/stock/ulgx#NASDAQ">ULGX</a>) sees FY2014 sales of $15.0M-17.0M.

Urologix, Inc. Sees FY2014 Sales $15.0M-17.0M

Comments

Urologix

Urologix (ULGX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga